Rockefeller Capital Management L.P. Abbott Laboratories Transaction History

Rockefeller Capital Management L.P.

$36.3 Billion
Q3 2024

A detailed history of Rockefeller Capital Management L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 665,257 shares of ABT stock, worth $77.1 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

665,257

Previous 676,289 1.63%

Holding current value

$77.1 Million

Previous $70.3 Million 7.93%

% of portfolio

0.21%

Previous 0.2%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $1.1 Million - $1.3 Million	-11,032 Reduced 1.63%	665,257 $75.8 Million
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $1.67 Million - $1.86 Million	-16,572 Reduced 2.39%	676,289 $70.3 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $89,368 - $98,703	-816 Reduced 0.12%	692,861 $78.8 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $2.69 Million - $3.3 Million	29,854 Added 4.5%	693,677 $76.4 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $3.44 Million - $4.13 Million	35,993 Added 5.73%	663,823 $64.3 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $19.4 Million - $21.7 Million	192,868 Added 44.34%	627,830 $68.4 Million
Q1 2023 May 17, 2023	BUY	$96.86 - $114.01 $396,157 - $466,300	4,090 Added 0.95%	434,962 $44 Million
Q4 2022 Mar 06, 2023	BUY	$95.06 - $111.52 $828,352 - $971,785	8,714 Added 2.06%	430,872 $47.3 Million
Q3 2022 Nov 02, 2022	BUY	$96.76 - $112.03 $5.95 Million - $6.88 Million	61,441 Added 17.03%	422,158 $40.8 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $5.08 Million - $6.14 Million	49,732 Added 15.99%	360,717 $39.2 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $1.12 Million - $1.37 Million	-9,829 Reduced 3.06%	310,985 $36.8 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $900,094 - $1.1 Million	7,791 Added 2.49%	320,814 $45.2 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $3.35 Million - $3.7 Million	-28,691 Reduced 8.4%	313,023 $37 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $1.72 Million - $2.02 Million	16,238 Added 4.99%	341,714 $39.6 Million
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $898,583 - $1.06 Million	8,256 Added 2.6%	325,476 $39 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $5.32 Million - $5.8 Million	50,672 Added 19.01%	317,220 $34.7 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $1.91 Million - $2.32 Million	-20,854 Reduced 7.26%	266,548 $29 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $1.52 Million - $1.95 Million	19,865 Added 7.43%	287,402 $26.3 Million
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $2.25 Million - $3.29 Million	-35,813 Reduced 11.81%	267,537 $21.1 Million
Q4 2019 Feb 07, 2020	BUY	$78.51 - $87.4 $1.4 Million - $1.56 Million	17,822 Added 6.24%	303,350 $26.3 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $939,686 - $1.02 Million	11,482 Added 4.19%	285,528 $23.9 Million
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $356,310 - $415,565	-4,889 Reduced 1.75%	274,046 $23 Million
Q1 2019 May 10, 2019	BUY	$66.22 - $80.06 $301,301 - $364,273	4,550 Added 1.66%	278,935 $22.3 Million
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $67,199 - $76,126	-1,025 Reduced 0.37%	274,385 $19.8 Million
Q3 2018 Nov 02, 2018	SELL	$60.81 - $73.36 $671,889 - $810,554	-11,049 Reduced 3.86%	275,410 $20.2 Million
Q2 2018 Jul 31, 2018	SELL	$57.57 - $63.54 $141,276 - $155,927	-2,454 Reduced 0.85%	286,459 $17.5 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $16.3 Million - $18.4 Million	288,913 New	288,913 $17.3 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Abbott Laboratories Transaction History